3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
6
Not yet recruiting
3
Unknown
2
Active not recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Carcinoma, Non-Small-Cell Lung
4
Colorectal Neoplasms
3
Skin Neoplasms
2
Melanoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Turcot syndrome
1
Solid Tumors
1
Solid Tumor, Adult
1
Rectal Neoplasms
1
Radiation Pneumonitis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Non-small Cell Lung Cancer Metastatic
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Motor Activity
1
Lung Neoplasms
1
Locally Advanced Esophageal Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Interventions
Carboplatin
11
pembrolizumab
10
Paclitaxel
10
Fluorouracil
9
Oxaliplatin
8
Radiotherapy
7
Nivolumab
7
Leucovorin
6
Cisplatin
6
Radiotherapy, Intensity-Modulated
5
Magnetic Resonance Spectroscopy
5
Taxes
4
durvalumab
3
Trastuzumab
3
Capecitabine
3
relatlimab
2
Surgical Procedures, Operative
2
Standard of Care
2
Specimen Handling
2
Radiation
2
Proton Therapy
2
Practice Guidelines as Topic
2
Irinotecan
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Cetuximab
2
Blood Specimen Collection
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Neoplasms
×
Immune Checkpoint Inhibitors
×
Clear all
NCT05621707
2026-02-02
RICE
Shanghai Chest Hospital
Phase 2
Active not recruiting
50 enrolled
NCT05491616
2025-02-13
SANO-3
Erasmus Medical Center
Phase 2
Active not recruiting
77 enrolled